The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Cerner Corp

Nasdaq: CERN
Last

(U.S.) $53.71

Today's change-0.58 -1.07%
Updated February 9 4:00 PM EST. Delayed by at least 15 minutes.
 

Cerner Corp

Nasdaq: CERN
Last

(U.S.) $53.71

Today's change-0.58 -1.07%
Updated February 9 4:00 PM EST. Delayed by at least 15 minutes.

Cerner Corp down (U.S.)$0.58

Cerner Corp closed lower Tuesday, dropping (U.S.)$0.58 or 1.07% to (U.S.)$53.71. Over the last five days, shares have lost 5.17% and sit 1.51% above their 52-week low. This security has underperformed the S&P 500 by 10.18% during the last year.

Key company metrics

  • Open(U.S.) $53.64
  • Previous close(U.S.) $54.29
  • High(U.S.) $54.67
  • Low(U.S.) $53.39
  • Bid / Ask(U.S.) $52.16 / (U.S.) $53.74
  • YTD % change-10.74%
  • Volume2,333,266
  • Average volume (10-day)2,010,495
  • Average volume (1-month)1,953,377
  • Average volume (3-month)2,292,886
  • 52-week range(U.S.) $52.91 to (U.S.) $75.72
  • Beta0.62
  • Trailing P/E36.21×
  • P/E 1 year forward26.20×
  • Forward PEG1.51×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.48
Updated February 9 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.48%

Based on its net profit margin of 12.48%, Cerner Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.02%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 03, 201510/03/2015Jul 04, 201507/04/2015Apr 04, 201504/04/2015Jan 03, 201501/03/2015
Revenue1,1281,126996926
Total other revenue--------
Total revenue1,1281,126996926
Gross profit937934827753
Total cost of revenue191192169173
Total operating expense913954829721
Selling / general / administrative565599533451
Research & development1031099879
Depreciation / amortization54542928
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total-------10
Operating income215172167205
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax216171167208
Income after tax147115111148
Income tax, total68565661
Net income147115111148
Total adjustments to net income--------
Net income before extra. items147115111148
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items147115111148
Inc. avail. to common incl. extra. items147115111148
Diluted net income147115111148
Dilution adjustment--------
Diluted weighted average shares351352352350
Diluted EPS excluding extraordinary itemsvalue per share0.420.330.320.42
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.420.330.320.42